Amiodarone for Tachyarrhythmias: Pharmacology, Kinetics, and Efficacy
- 1 February 1983
- journal article
- review article
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 17 (2), 100-104
- https://doi.org/10.1177/106002808301700203
Abstract
Amiodarone, although widely studied in Europe, is a recent addition to the investigational antiarrhythmics being used in the U.S. Pharmacologically, its primary cardiac effects are to increase coronary artery blood flow, increase the effective refractory period, and produce an atropine-resistant bradycardia. Amiodarone is incompletely (~ 50 percent) and slowly (peak serum concentration ~ 6 h) absorbed. With chronic administration, it deposits both in adipose tissue and in organs with high blood perfusion. It has an apparent elimination half-life of 15–45 days, which presents unique dosing problems. The apparent therapeutic range is 0.6-3 μg/ml. Amiodarone is 85–95 percent effective in the treatment of atrial tachyarrhythmias and 70–80 percent effective in ventricular tachyarrhythmias. It appears to be of particular value in chronic atrial fibrillation/flutter because it may be able to maintain sinus rhythm after cardioversion. Side effects, although uncommon, may prevent the drug from becoming a standard of therapy. Drug interactions, particularly with warfarin and digoxin, as well as pulmonary fibrosis are of concern.Keywords
This publication has 16 references indexed in Scilit:
- High‐Pressure Liquid Chromatography of Amiodarone in Biological FluidsJournal of Pharmaceutical Sciences, 1981
- Pharmacokinetics of amiodarone after intravenous and oral administrationEuropean Journal of Clinical Pharmacology, 1981
- ACCP AbstractsDrug Intelligence & Clinical Pharmacy, 1980
- Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease.Circulation, 1979
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- The effects of amiodarone on the sinus node activity of the rabbit heartEuropean Journal of Pharmacology, 1976
- Effect of amiodarone in the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1976
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970
- Recherches dans la série des benzofuranesCardiology, 1969